12:21:18 AM PDT - Sunday, September 25th, 2022

8 investors discuss what’s ahead for reproductive health startups in a post-Roe world  

By Editor - Thu Sep 22, 11:40 am

One of the most pressing issues the U.S. has to prepare for, perhaps, is the future it faces after the toppling of Roe v. Wade. Come the midterm elections, voters will weigh in on candidates and, consequently, measures that will dictate abortion access and other human rights issues. The role venture capital must play in all of this is becoming clearer: There has been a push to fund more reproductive health companies , include healthcare access in ESG investments  and reevaluate the safest places to open a business for women employees. To get a clearer picture of what lies ahead, TechCrunch+ surveyed eight investors and learned what they think venture’s role should be in a post-Roe world. McKeever Conwell, the founder of RareBreed Ventures, noted the tenuous relationship between venture money and ethics

See the original post here:

8 investors discuss what’s ahead for reproductive health startups in a post-Roe world

Leave a Reply

You must sign in to post a comment.